These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2577796

  • 1. [Mucolytic agents. Polycentric study of a carbocysteine-sobrerol combination].
    Gramiccioni E, Pamparana F, Messa A.
    Arch Monaldi Mal Torace; 1989; 44(4-6):791-3. PubMed ID: 2577796
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
    Casali L, Rampulla C, Rossi A.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Studies of the clinical effectiveness of the mucolytic drug, S-carboxymethylcysteine, in the therapy of acute and chronic bronchitis].
    Magliulo E, Bonizzoni D, Cattaneo E, Scevola D, Concia E.
    Minerva Med; 1975 Apr 04; 66(25):1187-97. PubMed ID: 1134660
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Theory and practice of the use of expectorants reviewed from clinical aspects.
    Nagy G.
    Ther Hung; 1984 Apr 04; 32(1):6-12. PubMed ID: 6400475
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug].
    Fossati C.
    Clin Ter; 1975 Jul 15; 74(1):63-82. PubMed ID: 770054
    [No Abstract] [Full Text] [Related]

  • 12. [Expectorants, antitussive agents, bronchospasmolytic agents. Therapy of obstructive respiratory tract diseases].
    Haen E.
    Med Monatsschr Pharm; 1989 Nov 15; 12(11):344-55. PubMed ID: 2685526
    [No Abstract] [Full Text] [Related]

  • 13. [Medical treatment of seromucous otitis].
    Renou G, Ketari M, Toutée JP, Benzaken J.
    Rev Laryngol Otol Rhinol (Bord); 1989 Nov 15; 110(3):327-8. PubMed ID: 8638061
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Sobrerol and chronic bronchitis].
    Pozzi E.
    Arch Monaldi Mal Torace; 1989 Nov 15; 44(4-6):797-806. PubMed ID: 2577798
    [No Abstract] [Full Text] [Related]

  • 16. The human nasal mucous membrane during chronic inflammation, before and after muco-active therapy: a study using scanning electron microscopy.
    Pacini P, Gulisano M, Dallai S, Polli G, Gheri G.
    Ital J Anat Embryol; 1993 Nov 15; 98(4):231-41. PubMed ID: 8018015
    [Abstract] [Full Text] [Related]

  • 17. [Controlled study of mucolytic agent associated with kinesitherapy in obstructive lung diseases (author's transl)].
    Lulling J, Dubois G.
    Acta Tuberc Pneumol Belg; 1973 Nov 15; 64(1):74-9. PubMed ID: 4358503
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of mucolytics in COPD: A Delphi consensus study.
    Papi A, Avdeev S, Calverley PMA, Cordeiro CR, Jesenak M, Koblížek V, Petkova D, Rogliani P, Tarraf H, Tzanakis N, Ulmeanu R, Uzaslan E, Adir Y.
    Respir Med; 2020 Dec 15; 175():106190. PubMed ID: 33217537
    [Abstract] [Full Text] [Related]

  • 20. [Chronic-obstructive lung diseases. The treatment of chronic-obstructive lung diseases with transbronchin].
    Haage W.
    ZFA (Stuttgart); 1978 Jul 31; 54(21):1099-102. PubMed ID: 685402
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.